Skip to main content
. Author manuscript; available in PMC: 2015 Aug 26.
Published in final edited form as: J Clin Pathol. 2014 Jun 5;67(8):690–696. doi: 10.1136/jclinpath-2013-202161

Table 3.

AXL immunohistochemical expression compared with clinicopathologic variables for patients with luminal B tumours

Characteristic (n=203) Number Axl H-Score median (min, max) p Value
Age (mean years±SD) 58±13
Stage 0.427
 I 117 15 (0, 300)
 II 68 15 (0, 300)
 III 18 10 (0, 80)
Tumour size 0.745
 T1 142 17.5 (0, 300)
 T2 55 10 (0, 300)
 T3 6 10 (0, 20)
Node status 0.652
 N0 143 15 (0, 300)
 N1 45 30 (0, 300)
 N2 12 10 (0, 80)
 N3 3 40 (0, 80)
Histologic grade 0.523
 1 7 10 (0, 200)
 2 69 15 (0, 300)
 3 107 15 (0, 300)
 ILC 20 10 (0, 300)
Lymphovascular invasion 0.981
 Present 45 20 (0, 270)
 Absent 158 10 (0, 300)

ILC, invasive lobular carcinoma.